Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Khalifa

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal for Immunotherapy of Cancer|July 15, 2024
Assessing the implications of sentinel lymph node removal in cervical cancer: an immunogenetic perspective - a SENTICOL ancillary studyGaurav Thareja, Anna Salvioni, Françoise Lauzeral-Vizcaino, et al.
Frontiers in Oncology|January 28, 2022
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective StudyIngrid Masson, Martine Bellanger, Geneviève Perrocheau, et al.
Journal of Neuro-Oncology|August 10, 2016
Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?Jonathan Khalifa, Fatima Tensaouti, Jean-Albert Lotterie, et al.
Archives of Cardiovascular Diseases|January 22, 2021
Focus on stereotactic radiotherapy: A new way to treat severe ventricular arrhythmias?Frédéric Sacher, Estelle Gandjbakhch, Philippe Maury, et al.
Clinical Lung Cancer|December 10, 2017
Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I StudyCarole Massabeau, Jonathan Khalifa, Thomas Filleron, et al.
World Journal of Urology|June 2, 2021
Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centersSimone Albisinni, Marco Moschini, Ettore Di Trapani, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2026
OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trialHugo Corda, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2021
Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladderJonathan Khalifa, Stéphane Supiot, Géraldine Pignot, et al.
Frontiers in Oncology|December 11, 2023
Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancerJonathan Khalifa, Noémie Thébault, Clara-Maria Scarlata, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 9, 2025
Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysisNajlaa Alyamani, Enrico Clementel, Paul Sargos, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|July 15, 2024
Assessing the implications of sentinel lymph node removal in cervical cancer: an immunogenetic perspective - a SENTICOL ancillary studyGaurav Thareja, Anna Salvioni, Françoise Lauzeral-Vizcaino, et al.
Frontiers in Oncology|January 28, 2022
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective StudyIngrid Masson, Martine Bellanger, Geneviève Perrocheau, et al.
Journal of Neuro-Oncology|August 10, 2016
Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?Jonathan Khalifa, Fatima Tensaouti, Jean-Albert Lotterie, et al.
Archives of Cardiovascular Diseases|January 22, 2021
Focus on stereotactic radiotherapy: A new way to treat severe ventricular arrhythmias?Frédéric Sacher, Estelle Gandjbakhch, Philippe Maury, et al.
Clinical Lung Cancer|December 10, 2017
Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I StudyCarole Massabeau, Jonathan Khalifa, Thomas Filleron, et al.
World Journal of Urology|June 2, 2021
Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centersSimone Albisinni, Marco Moschini, Ettore Di Trapani, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2026
OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trialHugo Corda, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2021
Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladderJonathan Khalifa, Stéphane Supiot, Géraldine Pignot, et al.
Frontiers in Oncology|December 11, 2023
Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancerJonathan Khalifa, Noémie Thébault, Clara-Maria Scarlata, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 9, 2025
Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysisNajlaa Alyamani, Enrico Clementel, Paul Sargos, et al.
Pageof 6